Parexel quickens the PACE with new hires
This article was originally published in Scrip
Executive Summary
The CRO Parexel International has appointed several executives to its global team of late phase and observational research experts in its PACE (Peri-Approval Clinical Excellence) group. This team now consists of Peggy Schrammel, vice-president and global head portfolio management, Neal Mantick, senior director, global observational research, Dr David Brown, vice-president, epidaemiology, and Dr Deborah Lubeck, vice-president, health economics and outcomes research.